Biocompatibility and Biocorrosion of Hydroxyapatite-Coated Magnesium Plate: Animal Experiment.
Ho-Kyung Lim, Soo-Hwan Byun, Jae-Man Woo, Sae-Mi Kim, Sung-Mi Lee, Bong-Ju Kim, Hyoun-Ee Kim, Jung-Woo Lee, Soung-Min Kim, Jong-Ho Lee · Materials (Basel, Switzerland) · 2017
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In Sprague-Dawley rats, the delayed and gradual resorption of HA-coated plates also showed reduced clinically observable side effects such as the rapid release of the hydrogen gas, wound dehiscence, or plate exposure. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in Sprague-Dawley rats. The delayed and gradual resorption of HA-coated plates also showed reduced clinically observable side effects such as the rapid release of the hydrogen gas, wound dehiscence, or plate exposure.
What the Researchers Studied
The researchers studied Sprague-Dawley rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
The method for the hydroxyapatite coating process proposed by Hiromoto et al. [ 9 ] was followed: specimens were soaked in 0.5 M ethylenediaminetetraacetic acid calcium disodium salt hydrate (Ca-EDTA) and 0.05 M potassium dihydrogenphosphate (KH 2 PO 4 ) solution, then heat-processed at 363 K for 2 h. The delayed and gradual resorption of HA-coated plates also showed reduced clinically observable side effects such as the rapid release of the hydrogen gas, wound dehiscence, or plate exposure.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was Sprague-Dawley rats. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.